IMMUNOVANT, INC. Voting Outcome
Historical shareholder voting results from retained filings, including every disclosed proposal and director nominee. Vote counts are as filed, not split-adjusted, and displayed in K/M/B/T. — means the category was not reported or no vote was held. Frequency votes preserve each choice. All retained years remain available through pagination.
| Meeting / report date | Proposal / nominee | Outcome | For (shares) | Against (shares) | Abstain (shares) | Withheld (shares) | Broker non-votes (shares) | Filed | Frequency choices (shares) | Document |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |